Review of Calvin Wai-Loon Ho, Juridification in Bioethics: Governance of Human Pluripotent Cell Research [Book Review]

American Journal of Bioethics 17 (11):W12-W13 (2017)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/15265161.2017.1378754

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Toward a better bioethics.Jason Scott Robert - 2009 - Science and Engineering Ethics 15 (3):283-291.
Moral complicity in induced pluripotent stem cell research.Mark T. Brown - 2009 - Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
Developments in stem cell research and therapeutic cloning: Islamic ethical positions, a review.Hossam E. Fadel - 2010 - Bioethics 26 (3):128-135.
Utilitarianism and Patents: Justification and Change.Ho Calvin Wai Loon - 2010 - Asian Bioethics Review 2 (3):202-217.
No ethical bypass of moral status in stem cell research.Mark Brown - 2011 - Bioethics 27 (1):12-19.
Some Ethical Concerns About Human Induced Pluripotent Stem Cells.Yue Liang Zheng - 2016 - Science and Engineering Ethics 22 (5):1277-1284.
Governance of Biomedical Research in Singapore and the Challenge of Conflicts of Interest.Calvin Wai Loon Ho, Leonardo D. de Castro & Alastair V. Campbell - 2014 - Cambridge Quarterly of Healthcare Ethics 23 (3):288-296.
Stem Cells Therapy and Research. Benefits and Ethical Challences.Nicolae Ovidiu Grad, Ionel Ciprian Pop & Ion Aurel Mironiuc - 2012 - Journal for the Study of Religions and Ideologies 11 (32):190-205.
The ethics and politics of small sacrifices in stem cell research.Glenn McGee & Arthur L. Caplan - 1999 - Kennedy Institute of Ethics Journal 9 (2):151-158.
Embryonic Stem Cell Patents and Human Dignity.David B. Resnik - 2007 - Health Care Analysis 15 (3):211-222.
Ethical Review of Research on Human Subjects at Unilever: Reflections on Governance.Mark Sheehan, Vernon Marti & Tony Roberts - 2013 - Bioethics 28 (6):284-292.
Uncertain translation, uncertain benefit and uncertain risk: Ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.Ronald K. F. Fung & Ian H. Kerridge - 2011 - Bioethics 27 (2):89-96.
Time to reconsider stem cell ethics--the importance of induced pluripotent cells.S. Holm - 2008 - Journal of Medical Ethics 34 (2):63-64.
Global Governance in Human Embryonic Stem Cell Science: Standardisation and Bioethics in Research and Patenting.Catherine Waldby & Brian Salter - 2008 - Studies in Ethics, Law, and Technology 2 (1).
Oversight framework over oocyte procurement for somatic cell nuclear transfer: Comparative analysis of the Hwang Woo Suk case under south korean bioethics law and U.s. Guidelines for human embryonic stem cell research.Mi-Kyung Kim - 2009 - Theoretical Medicine and Bioethics 30 (5):367-384.

Analytics

Added to PP
2017-11-21

Downloads
33 (#472,429)

6 months
1 (#1,510,037)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Bioethics as a Governance Practice.Jonathan Montgomery - 2016 - Health Care Analysis 24 (1):3-23.

Add more references